Strength
4.1 meq/g
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534016616
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL; RECTAL
Last Updated
4/22/2026
Active Ingredients
SODIUM POLYSTYRENE SULFONATEApproval Type
Generic (ANDA)
FDA Application
ANDA204071On Market Since
1/24/2017
Related Drugs
Same classification
No related drugs found.